• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[眼部细菌分离株的体外氟喹诺酮耐药性]

[In vitro fluoroquinolone resistance in ocular bacterial isolates].

作者信息

Sun Xu-guang, Wang Zhi-quen, Li Ran, Chen Lin, Jin Xiu-ying, Luo Shi-yun

机构信息

Beijing Institute of Ophthalmology, Beijing Tong Ren Ophthalmic Center, Capital University of Medical Sciences, Beijing 100730, China.

出版信息

Zhonghua Yan Ke Za Zhi. 2003 Mar;39(3):163-6.

PMID:12880574
Abstract

OBJECTIVE

To assess the in vitro resistance of ocular bacterial isolates to fluoroquinolone that are commonly used in the treatment of ocular infection.

METHODS

Ocular bacterial isolates (n = 347) from Beijing Institute of Ophthalmology were tested for their resistance to ofloxacin, ciprofloxacin and norfloxacin. In vitro susceptibility testing was determined by the Kirby-Bauer disk diffusion method.

RESULTS

The total number of ocular bacterial isolates was 347 from January, 1999 to December, 2000 including gram-positive cocci 192 (55.3%), gram-negative cocci 16 (4.6%), gram-positive bacilli 44 (12.7%), gram-negative bacilli 89 (25.7%), Nocardia 6 (1.7%). The percentage of resistance in total ocular bacterial isolates to ofloxacin, ciprofloxacin and norfloxacin was 28.5%, 25.9% and 34.9% respectively. The resistance of streptococcus species to ofloxacin (5.9%) and ciproloxacin (11.8%) was significantly lower than gentamycin (52.9%) and tobramycin (70.6%) (P < 0.01), and to norfloxacin (23.5%) was significantly lower than tobramycin (P < 0.01). Pseudomonas showed significantly lower resistance to ciprofloxacin (6%) ofloxacin (14.0%) and norfloxacin (14.0%) than gentamycin (42.0%) (P < 0.01 and P < 0.05). The percentage of resistance in staphylococcus species to norfloxacin (46.8%) was higher than gentamycin (30.8%) and tobramycin (27.6%) (P < 0.05 and P < 0.01 separately). The resistance of gram-positive bacilli to ofloxacin, ciproloxacin and norfloxacin. was equivalent (P > 0.05).

CONCLUSIONS

The fluoroquinolones, ofloxacin and ciprofloxacin have higher overall in vitro efficacy on most of the ocular bacteria than gentamycin and tobramycin, but ofloxacin and ciprofloxacin are equivalent to gentamycin and tobramycin in efficacy against staphylococcus species.

摘要

目的

评估眼部细菌分离株对治疗眼部感染常用氟喹诺酮类药物的体外耐药性。

方法

对北京眼科研究所的眼部细菌分离株(n = 347)进行氧氟沙星、环丙沙星和诺氟沙星耐药性检测。体外药敏试验采用 Kirby-Bauer 纸片扩散法。

结果

1999 年 1 月至 2000 年 12 月共收集眼部细菌分离株 347 株,其中革兰阳性球菌 192 株(55.3%),革兰阴性球菌 16 株(4.6%),革兰阳性杆菌 44 株(12.7%),革兰阴性杆菌 89 株(25.7%),诺卡菌 6 株(1.7%)。眼部细菌分离株对氧氟沙星、环丙沙星和诺氟沙星的耐药率分别为 28.5%、25.9%和 34.9%。链球菌属对氧氟沙星(5.9%)和环丙沙星(11.8%)的耐药率显著低于庆大霉素(52.9%)和妥布霉素(70.6%)(P < 0.01),对诺氟沙星(23.5%)的耐药率显著低于妥布霉素(P < 0.01)。铜绿假单胞菌对环丙沙星(6%)、氧氟沙星(14.0%)和诺氟沙星(14.0%)的耐药率显著低于庆大霉素(42.0%)(P < 0.01 和 P < 0.05)。葡萄球菌属对诺氟沙星(46.8%)的耐药率高于庆大霉素(30.8%)和妥布霉素(27.6%)(分别为 P < 0.05 和 P < 0.01)。革兰阳性杆菌对氧氟沙星、环丙沙星和诺氟沙星的耐药率相当(P > 0.05)。

结论

氟喹诺酮类药物氧氟沙星和环丙沙星对大多数眼部细菌的总体体外抗菌效果高于庆大霉素和妥布霉素,但氧氟沙星和环丙沙星对葡萄球菌属的抗菌效果与庆大霉素和妥布霉素相当。

相似文献

1
[In vitro fluoroquinolone resistance in ocular bacterial isolates].[眼部细菌分离株的体外氟喹诺酮耐药性]
Zhonghua Yan Ke Za Zhi. 2003 Mar;39(3):163-6.
2
[Analysis on susceptibility of ocular bacterial pathogens to four kinds of fluoroquinolone].[眼部细菌病原体对四种氟喹诺酮类药物的敏感性分析]
Zhonghua Yan Ke Za Zhi. 2008 Mar;44(3):233-6.
3
[In vitro activity of trovafloxacin, of other fluoroquinolones and of related antimicrobials against clinical isolates. Grupo colaborativo WHONET-Argentina].
Medicina (B Aires). 1999;59 Suppl 1:8-16.
4
In vitro antibiotic susceptibilities of ocular isolates in North and South America. In Vitro Antibiotic Testing Group.
Cornea. 1998 Jan;17(1):79-87. doi: 10.1097/00003226-199801000-00013.
5
The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics.正常眼部细菌菌群对4种氟喹诺酮类抗生素的耐药模式。
Cornea. 2009 Jan;28(1):68-72. doi: 10.1097/ICO.0b013e318182259b.
6
Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.细菌性角膜炎中氟喹诺酮耐药性的新出现:一项5年回顾
Ophthalmology. 1999 Jul;106(7):1313-8.
7
Comparison of in vitro susceptibilities of ocular bacterial isolates to gatifloxacin and other topical antibiotics.眼部细菌分离株对加替沙星及其他局部用抗生素的体外敏感性比较。
Ophthalmic Res. 2005 May-Jun;37(3):117-22. doi: 10.1159/000084270. Epub 2005 Mar 4.
8
Emergence of resistance to fluoroquinolones among gram positive and gram negative clinical isolates.革兰氏阳性和革兰氏阴性临床分离株中对氟喹诺酮类药物耐药性的出现。
Pak J Pharm Sci. 2012 Oct;25(4):877-81.
9
In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.氟喹诺酮类药物对巴西圣保罗眼部细菌分离株的体外活性。
Cornea. 2007 Feb;26(2):194-8. doi: 10.1097/01.ico.0000248379.78777.f6.
10
The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.革兰氏阴性菌和革兰氏阳性菌对氧氟沙星的敏感性。
Chemioterapia. 1987 Feb;6(1):17-22.

引用本文的文献

1
Distribution of bacterial keratitis and emerging resistance to antibiotics in China from 2001 to 2004.2001年至2004年中国细菌性角膜炎的分布及对抗生素的新出现耐药情况
Clin Ophthalmol. 2008 Sep;2(3):575-9. doi: 10.2147/opth.s1774.